Latest Angiotensin II receptor antagonists Stories
LONDON, April 16, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research, ''Antihypertensive Therapeutics in
2015 Global Valsartan Industry Research Report of 143 pages now readily available at DeepResearchReports.com database. Dallas, Texas (PRWEB) April 15, 2015
POTTERS BAR, England and PITTSBURGH, March 31, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced the U.S.
New research report “Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 – Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries” elaborated by
The San Diego injury law firm comments on Mayo Clinic Proceedings regarding Benicar case studies, in light of a recent lawsuit filed against Benicar's manufacturer, Daiichi Sankyo, for alleged
Heart Healthy for a Lifetime: Medicationdiscountcard.com Focuses on Access to Coupons for Heart-Related Medications During American Heart Month Houston, TX (PRWEB)
FORT LAUDERDALE-DAVIE, Fla., Feb. 2, 2015 /PRNewswire/ -- Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure.
MUMBAI and BALTIMORE, January 6, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
PITTSBURGH, Jan. 5, 2015 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
CHAPEL HILL, N.C., Nov. 14, 2014 /PRNewswire/ -- In 1997, Novartis launched its antihypertension treatment Diovan into a crowded marketplace.
- A person in a secondary role, specifically the second most important character (after the protagonist).